Scientipole Ile-de-France Capital
Venture capitalSaclay · Pre-Seed–Seed · 8 people tracked
Investment thesis
Scientipôle Capital is a seed-stage investor based in the Saclay plateau of the Île-de-France region, backing innovative startups. The team brings long experience in financing innovative early-stage companies and a culture of tailored support spanning finance, industrialization, sales and marketing, and human resources. Its stable, continuous presence alongside partners such as incubators, tech transfer offices (SATT), universities and schools, honor-loan platforms, competitiveness clusters, banks, and business angels enables qualified deal sourcing and effective hands-on support. Since January 2021 the vehicle has been managed by Auriga Partners, an AMF-approved asset manager.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website
Frequently asked questions
- What stage does Scientipole Ile-de-France Capital invest at?
- Scientipole Ile-de-France Capital invests at the Pre-Seed, Seed stages.
- What sectors does Scientipole Ile-de-France Capital focus on?
- Scientipole Ile-de-France Capital focuses on Deep Tech.
- Where is Scientipole Ile-de-France Capital located?
- Scientipole Ile-de-France Capital is headquartered in Saclay, FR.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blueyard is a small equal partnership with offices in the US and Europe, investing in early-stage companies.
Boundary Capital invests in high-growth private technology companies with the aim of positively impacting millions of lives, focusing on life sciences, AI, and engineering.